Journal of Thyroid Cancer

ISSN: 2574-4496

JTC

Ongoing Special Issue
 
Special Issue On -  Thyroid Cancer: Current Updates
 
Special issue By Manas sahoo
 
This special issue calls for original papers with important and novel contributions related to –“ Thyroid cancer
 

Topics of interests include

  • post SPECT
  • pre SPECT
  • PET_CT in management
  • medullary CA thyroid
  • Anaplastic CA thyroid

We look for high quality publications on - "Thyroid Cancer: Current Updates".

Reviews which include the comparative view, Original research papers as well as short communications and letters on new developments and applications are welcome and are to be written in Standard English. Formatting of manuscript with headings and Sub headings is necessary and views are to be presented clearly. New approaches are mainly in interest.


Metrics:

  • Last Date of Submissions: Will be updated soon
  • Acceptance period:
    • 1st round – 1 month
    • 2nd round – 3 weeks
    • 3rd round – 2 weeks
    • 4th round – 1 week
  • Last Date of Publication: Will be updated soon
  • People involved: Dr. Manas sahoo - Editor

 

Dr. Manas sahoo 

Editor

 


The importance and need for this special issue:

The emerging challenges and solutions provided by Modern methods are extremely interesting and are of great hope for the future.  This platform brings forth the outstanding research information in the specified field which helps researchers to have a perfect source specifically designed for research on "Thyroid cancer" with much emphasis on immunity and cure

This resource not only affects the way the trending research is evolving, but also creates tremendous new support for the now working researchers to put forth their work at a worthy and specifically targeted readership for the desired proper usage of the knowledge dissipated by you.

This research area has many new challenges in the future and many challenges still remain to be resolved, and we hope that this issue will help to open new horizons for research on Thyroid cancer.